PROGRAM DESCRIPTION AND OBJECTIVES
The course is designed to assist nephrologists and renal pathologists (including nephrology and renal pathology trainees) in diagnosing and managing the most common forms of medical renal disease, including diseases that target the glomerulus, tubules, interstitium, and blood vessels.
The activity will span three days and include lectures covering the following content areas: Nephrotic syndrome, Nephritic syndrome, Genetics, Tubulointerstitial, Vascular Disease, Transplant & Dysproteinemia. These lectures will be delivered live in front of an audience but also streamed simultaneously for virtual participants; all participants will have access to these lectures for 3 months after the conference.
Upon completion of this activity, participants will be better able to
- Identify the role of complement in the pathophysiology of glomerular diseases and how novel complement-targeting therapies can fit into treatment patterns.
- Enhance diagnostic suspicion for a genetically mediated form of glomerular disease and facilitate rapid referral for genetic testing.
- Assess which patients would benefit from repeat biopsies in the management of their glomerular diseases.
WEDNESDAY, JULY 16, 2025
Morning Sessions
| Session Title | Speaker(s) |
|---|
| Registration; Continental Breakfast | |
| Welcome and Introduction | Glen S. Markowitz, MD |
| Histophysiology of the Glomerulus | Vivette D. D’Agati, MD |
| Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) | Agnes B. Fogo, MD |
| Refreshment Break | |
| Current Therapy of MCD and FSGS | Gerald B. Appel, MD |
| Membranous Nephropathy (MN): Pathology | Glen S. Markowitz, MD |
| Membranous Nephropathy: New Antigens & New Insights | Sanjeev Sethi, MD, PhD |
Afternoon Sessions
| Session Title | Speaker(s) |
|---|
| Working Lunch: Renal Biopsy: Clinical Cases | |
| Treatment and Immune Surveillance in MN | Laurence H. Beck, Jr., MD, PhD |
| Membranoproliferative GN & C3 Glomerulopathy: Pathology | Miroslav Sekulic, MD |
| Refreshment Break | |
| C3 Glomerulopathy: Diagnosis and Management | Andrew S. Bomback, MD, MPH |
| Pathology of Diabetic Kidney Disease | Charles E. Alpers, MD |
| State of the Art Lecture: Glomerular Disease in Pregnancy | Michelle A. Hladunewich, MD, FRCP(C), MSc |
| Adjourn | |
THURSDAY, JULY 17, 2025
Morning Sessions
| Session Title | Speaker(s) |
|---|
| Registration; Continental Breakfast | |
| Crescentic Glomerulonephritis and ANCA & Anti-GBM Disease | J. Charles Jennette, MD |
| Treatment of Crescentic Glomerulonephritis | Ronald J. Falk, MD |
| Refreshment Break | |
| Pathology of IgA Nephropathy and IgA Vasculitis | M. Barry Stokes, MD |
| Treatment of IgA Nephropathy and IgA Vasculitis | Pietro Canetta, MD |
| Infection Related Glomerulonephritis | Leal C. Herlitz, MD |
Afternoon Sessions
| Session Title | Speaker(s) |
|---|
| Working Lunch: Renal Biopsy: Clinical Cases | |
| Dysproteinemic Renal Disease | Dominick Santoriello, MD |
| 41ST ANNUAL CONRAD L. PIRANI LECTURE | Vivette D. D’Agati, MD |
| Recent Advances in Renal Amyloidosis, Fibrillary Glomerulonephritis, and Monoclonal Immunoglobulin Crystalline Nephropathies | Samih H. Nasr, MD |
| Refreshment Break | |
| Pathology of Thrombotic Microangiopathy and Viral Glomerular Disease | M. Barry Stokes, MD |
| Treatment of Thrombotic Microangiopathy | Jai Radhakrishnan, MD, MS |
| Clinical and Therapeutic Aspects of Viral-mediated Glomerular Disease | Meghan E. Sise, MD, MS |
| Adjourn | |
FRIDAY, JULY 18, 2025
Morning Sessions
| Session Title | Speaker(s) |
|---|
| Registration; Continental Breakfast | |
| Hereditary Nephropathies | Agnes B. Fogo, MD |
| Integrating the Renal Biopsy with Genetic Testing | Dominick Santoriello, MD & Hila Milo Rasouly, PhD |
| State of the Art Lecture: Updates on APOL1 | Simone Sanna-Cherchi, MD |
| Refreshment Break | |
| Pathology of Lupus Nephritis | Vivette D. D’Agati, MD |
| Modern Therapies for Lupus Nephritis | Gerald B. Appel, MD |
Afternoon Sessions
| Session Title | Speaker(s) |
|---|
| Working Lunch: Renal Biopsy: Clinical Cases | |
| Renal Transplant Pathology Part 1: Rejection | Robert B. Colvin, MD |
| Renal Transplant Pathology Part 2: Drug Toxicity, Infections, and Recurrent & De Novo Glomerular Disease | Ibrahim Batal, MD |
| Refreshment Break | |
| Acute Interstitial Nephritis | Satoru Kudose, MD |
| Onconephrology: Clinical Aspects of Drug Toxicity | Meghan E. Sise, MD, MS |
| The Pathology of Nephrotoxicity | Glen S. Markowitz, MD |
| Adjourn | |
